BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25692621)

  • 1. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.
    Dilwali S; Roberts D; Stankovic KM
    Cancer Biol Ther; 2015; 16(1):170-5. PubMed ID: 25692621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
    Zhao Y; Liu P; Zhang N; Chen J; Landegger LD; Wu L; Zhao F; Zhao Y; Zhang Y; Zhang J; Fujita T; Stemmer-Rachamimov A; Ferraro GB; Liu H; Muzikansky A; Plotkin SR; Stankovic KM; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2077-E2084. PubMed ID: 29440379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
    Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
    J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotrophic factor expression in vestibular schwannoma. An overview].
    Diensthuber M; Lenarz T; Stöver T
    Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
    Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
    Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue.
    Taurone S; Bianchi E; Attanasio G; Di Gioia C; Ierinó R; Carubbi C; Galli D; Pastore FS; Giangaspero F; Filipo R; Zanza C; Artico M
    Mol Med Rep; 2015 Jul; 12(1):737-45. PubMed ID: 25738867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells.
    Sulpice E; Ding S; Muscatelli-Groux B; Bergé M; Han ZC; Plouet J; Tobelem G; Merkulova-Rainon T
    Biol Cell; 2009 Sep; 101(9):525-39. PubMed ID: 19281453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.
    Kersigo J; Gu L; Xu L; Pan N; Vijayakuma S; Jones T; Shibata SB; Fritzsch B; Hansen MR
    Laryngoscope; 2021 Jan; 131(1):E259-E270. PubMed ID: 32438526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
    Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
    Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Fos is necessary for HGF-mediated gene regulation and cell migration in Schwann cells.
    Ko KR; Lee J; Nho B; Kim S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2855-2860. PubMed ID: 30103949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis.
    Zhang N; Xie F; Gao W; Yu S; Qiu L; Lin W; Sun Y; Jia T
    Mol Med Rep; 2015 Apr; 11(4):2797-804. PubMed ID: 25504327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
    Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
    Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
    Awazu Y; Nakamura K; Mizutani A; Kakoi Y; Iwata H; Yamasaki S; Miyamoto N; Imamura S; Miki H; Hori A
    Mol Cancer Ther; 2013 Jun; 12(6):913-24. PubMed ID: 23548264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the hepatocyte growth factor-cMET axis in cancer therapy.
    Blumenschein GR; Mills GB; Gonzalez-Angulo AM
    J Clin Oncol; 2012 Sep; 30(26):3287-96. PubMed ID: 22869872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
    Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
    Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
    Chen TT; Filvaroff E; Peng J; Marsters S; Jubb A; Koeppen H; Merchant M; Ashkenazi A
    EBioMedicine; 2015 May; 2(5):406-20. PubMed ID: 26137585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.
    Hansen MR; Roehm PC; Chatterjee P; Green SH
    Glia; 2006 Apr; 53(6):593-600. PubMed ID: 16432850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.